Open research questions in Pregnancy and Medication Impact
130 unresolved questions extracted from the limitations and future-work sections of 790 Pregnancy and Medication Impact papers in our library. Each links back to the study that raised it.
What the literature leaves open
However, the correlation between different onset times of the diseases and pregnancy outcomes remains unclear.
Pregnancy characteristics in patients with autoimmune diseases with different onset times and their relationship with pregnancy outcomes · 2026 · DOIINTRODUCTION: Exposure to potentially teratogenic medications during pregnancy is underinvestigated in Switzerland.
Exposure to potentially teratogenic medications before and during the first trimester of pregnancy compared to women of childbearing age: A retrospective analysis of Swiss claims data (2015–2021) · 2025 · DOI[1] on the possible preventive effect of metformin against hyperemesis gravidarum (HG) provides rare, population-level insight into an under-studied condition.
Metformin and Hyperemesis Gravidarum: Reframing a Metabolic Disorder Through the Lens of Placental Adaptation · 2025 · DOIIt remains unknown whether these changes translate to clinically meaningful adaptation or merely represent parallel pharmacologic effects.
Metformin and Hyperemesis Gravidarum: Reframing a Metabolic Disorder Through the Lens of Placental Adaptation · 2025 · DOICONCLUSIONS: This scoping review has identified the need for further research on approaches to care provision for nausea and vomiting in pregnancy and hyperemesis gravidarum.
A scoping review of models of care and services for nausea and vomiting in pregnancy and hyperemesis gravidarum · 2025 · DOIResearch priorities for hyperemesis gravidarum have been established, however little is known about the current landscape of literature on the health and social care provided to affected women.
A scoping review of models of care and services for nausea and vomiting in pregnancy and hyperemesis gravidarum · 2025 · DOIHowever, it remains to be determined whether ultrasound evaluation of fetal thymus size can help predict perinatal outcomes in diabetic women.
Valproate was consistently associated with an increased risk of neurodevelopmental disorders, whereas the results for other medications were sparse and conflicting.
Prenatal exposure to psychotropics and analgesics on cognitive, linguistic and educational outcomes – a scoping review with focus on validity and reliability of outcome measures · 2025 · DOICONCLUSION: Except for valproate, there is a concerning lack of studies on the impact of prenatal exposure to psychotropics and analgesics on cognitive, linguistic, and educational outcomes with existing studies yielding inconsistent findings.
Prenatal exposure to psychotropics and analgesics on cognitive, linguistic and educational outcomes – a scoping review with focus on validity and reliability of outcome measures · 2025 · DOIBACKGROUND: Limited research exists on the challenges women diagnosed with juvenile idiopathic arthritis (JIA) can face during pregnancy and breastfeeding, and if breastfeeding affects disease related factors.
Breastfeeding in women with juvenile idiopathic arthritis: results from a Norwegian quality register · 2025 · DOIBACKGROUND: Exposure to antibiotics during pregnancy is frequent, despite the limited evidence derived from clinical trials.
Real-world antibiotic utilization during pregnancy in Italy: a multiregional retrospective population-based study · 2025 · DOIIntroduction: Limited knowledge exists regarding the impact of paternal smoking and alcohol exposure on the development of allergic rhinitis in offspring.
Unveiling the hidden risk: paternal smoking and alcohol exposure prior to conception as independent factors for allergic rhinitis in children · 2024 · DOIHowever, the pathologies underlying NVP and HG and their associated loci are scarce.
Genome-wide association study of nausea and vomiting during pregnancy in Japan: the TMM BirThree Cohort Study · 2024 · DOICONCLUSIONS: Despite the gaps in knowledge about herb pharmacology, CPs demonstrated acceptable knowledge and practice regarding drug safety during pregnancy.
Knowledge and practice of community pharmacists regarding the safety of drugs during pregnancy: a cross-sectional study from a developing country · 2024 · DOIBACKGROUND: There is growing evidence of bidirectional associations between rheumatoid arthritis and adverse pregnancy outcomes (APOs) in observational studies, but little is known about the causal direction of these associations.
Rheumatoid arthritis and adverse pregnancy outcomes: a bidirectional two-sample mendelian randomization study · 2024 · DOIAlthough this disease is not rare amongst women of reproductive age, data regarding pregnancy outcomes have demonstrated conflicting results.
Obstetric and neonatal outcomes in women with Ankylosing spondylitis - an evaluation of a population database · 2024 · DOIOBJECTIVES: The medications used for autoimmune diseases have significantly evolved in recent years, but there is limited knowledge about how treatment practices changed during pregnancy.
Trends in medications for autoimmune disorders during pregnancy and factors for their discontinuation: a population-based study · 2024 · DOIImportance: Transplant recipients experience high rates of adverse pregnancy outcomes; however, contemporary estimates of the association between solid organ transplantation and adverse pregnancy outcomes are lacking.
There is a lack of comprehensive evaluation of the efficacy and safety of non-pharmaceutical Chinese medical therapies for nausea and vomiting of pregnancy. There is a need to evaluate the certainty of evidence using the GRADE criteria.
Non-pharmaceutical Chinese Medical Therapies for Nausea and Vomiting of Pregnancy: An Umbrella Review of Systematic Reviews and Meta-analyses of Randomized Controlled Trials · 2026 · DOIThere is a lack of harmonized guidance on a priority list of outcomes for non-interventional safety studies in pregnancy. The current variation in outcomes measured across studies limits comparability and creates inefficiencies in study conduct.
Outcomes of post-approval non-interventional safety studies in pregnancy: wide variation demonstrates need for further standardization · 2026 · DOIThe following limitations should be considered when reviewing the conclusions from this work. First, the sample size of total studies evaluated was small, and subgroups of these studies were even smaller. There were only 30 applicable studies and therefore these studies may not be representative of the entire body of post-marketing pregnancy safety studies. Further there were only 4 FDA studies done before 2019 and 4 vaccine studies overall, which made it difficult to draw conclusions for some assessments. The small sample size of total studies may be caused by a few factors: (1) Not all studies in the HMA-EMA catalogue were included due to a lack of a publicly available protocol, which limited our review. It is possible that studies that included a publicly available protocol may have been different from studies that did not. However, a protocol was required to identify all the study outcomes for this analysis. (2) The studies included in this review relied on the built-in filters on the HMA-EMA catalogue. If a study measured pregnancy outcomes in the pregnant population but was not properly labeled as such in the catalogue, it may have been excluded based on the filters applied in Figure 1. It is possible that other technical issues within the site may have provided a smaller sample size than intended. (3) This review excluded data from spontaneous case reports which may have omitted several studies and their outcomes. This criterion was necessary to restrict to studies with pre-defined outcomes. Studies using spontaneous case report data often are designed to report any adverse outcome occurring in pregnancy and thus the outcomes that are summarized in the final report are determined by the outcomes observed in the reported cases, rather than a predefined outcome list. (4) Sponsors may have variations in their policies regarding whether a study needs to be registered in the the EMA requires all post- HMA-EMA catalogue.
Outcomes of post-approval non-interventional safety studies in pregnancy: wide variation demonstrates need for further standardization · 2026 · DOIFuture research should investigate the incidence and prevalence of thiamine deficiency-related neuropathy in pregnant women with hyperemesis gravidarum. Further studies should examine the effectiveness of different rehabilitation programs in improving functional outcomes in patients with thiamine deficiency-related neuropathy.
Dry Beriberi During Pregnancy After Hyperemesis Gravidarum: A Case Report of Axonal Sensorimotor Polyneuropathy · 2026 · DOIThere is a lack of awareness about the risk of thiamine deficiency in pregnant women with hyperemesis gravidarum. There is a need for further research on the effectiveness of structured multidisciplinary rehabilitation programs in treating thiamine deficiency-related neuropathy.
Dry Beriberi During Pregnancy After Hyperemesis Gravidarum: A Case Report of Axonal Sensorimotor Polyneuropathy · 2026 · DOIThe use of black box models can be a limitation due to the lack of control and potential biases. The need for more data is a limitation of using AI to close the evidence gap. The opacity of certain artificial intelligence models is a concern.
The exclusion of pregnant women from clinical research leaves a significant evidence gap for drug safety. The current methods for determining medication safety in pregnant women are limited.
Most-cited papers in Pregnancy and Medication Impact
- The epidemiology of smoking during pregnancy: Smoking prevalence, maternal characteristics, and pregnancy outcomes · Nicotine & Tobacco Research · 2004 · 868 citations
- Maternal Infection Requiring Hospitalization During Pregnancy and Autism Spectrum Disorders · Journal of Autism and Developmental Disorders · 2010 · 775 citations
- Neonatal Drug Withdrawal · PEDIATRICS · 2012 · 723 citations
- Anticoagulation of Pregnant Women With Mechanical Heart Valves · Archives of Internal Medicine · 2000 · 594 citations
- Placental Passage of Antidepressant Medications · American Journal of Psychiatry · 2003 · 314 citations
- A meta-analysis of adverse perinatal outcomes in women with asthma · BJOG An International Journal of Obstetrics & Gynaecology · 2011 · 308 citations
- Delivery outcome after maternal use of antidepressant drugs in pregnancy: an update using Swedish data · Psychological Medicine · 2010 · 279 citations
- Associations between Drugs Administered during Pregnancy and Congenital Abnormalities of the Fetus · BMJ · 1971 · 273 citations
- Pharmacologic management of psychiatric illness during pregnancy: dilemmas and guidelines · American Journal of Psychiatry · 1996 · 248 citations
- Maternal Infection During Pregnancy and Autism Spectrum Disorders · Journal of Autism and Developmental Disorders · 2013 · 247 citations
Most recent work
- Allergy and Asthma Medication Use in Pregnancy: Safety and Clinical Considerations · The Journal of Allergy and Clinical Immunology In Practice · 2026
- Why It Is Unethical Not to Conduct Randomized Trials in Pregnancy · JAMA · 2026
- Possible Association Between Etanercept Use During Breastfeeding and Infant Somnolence, Hypotonia, and Feeding Difficulties: A Case Report and Literature Review · Breastfeeding Medicine · 2026
- Biologic treatment for asthma during pregnancy is not associated with reduced adverse pregnancy outcomes: a replication study · The Journal of Allergy and Clinical Immunology In Practice · 2026
- Pregnancy adverse events with immune checkpoint inhibitors in monotherapy and combination therapy in cancer: a disproportionality analysis · EClinicalMedicine · 2026
- Antiseizure medication use in pregnancy and the risk of poor fetal growth in the EURAP international registry: a prospective cohort study · The Lancet Neurology · 2026
- A new tool for pregnancy research: a unified definition for major congenital malformation across ICD eras · American Journal of Epidemiology · 2026
- Risk of Fetal Exposure to Teratogenic Medications: Development of Evidence for the Teratogenic Risk Impact and Mitigation (TRIM) Tool · Drug Safety · 2026
- Paracetamol in Pregnancy: Reassurance Amidst Uncertainty · BJOG An International Journal of Obstetrics & Gynaecology · 2026
- Pregnancy characteristics in patients with autoimmune diseases with different onset times and their relationship with pregnancy outcomes · BMC Pregnancy and Childbirth · 2026
Find a gap in your own Pregnancy and Medication Impact sub-topic
This page shows what the Pregnancy and Medication Impact literature already flags as unresolved. To narrow it to your specific question, run the guided finder — it searches the gap library on demand and checks candidates against 250M+ OpenAlex works.
Open the Research Gap Finder →